ABCL logo

AbCellera Biologics Inc. (ABCL) Accounts receivable

Annual accounts receivable:

$33.62M+$3.03M(+9.89%)
December 31, 2024

Summary

  • As of today (July 26, 2025), ABCL annual accounts receivable is $33.62 million, with the most recent change of +$3.03 million (+9.89%) on December 31, 2024.
  • During the last 3 years, ABCL annual accounts receivable has fallen by -$126.96 million (-79.07%).
  • ABCL annual accounts receivable is now -84.24% below its all-time high of $213.24 million, reached on December 31, 2020.

Performance

ABCL Accounts receivable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherABCLbalance sheet metrics

Quarterly accounts receivable:

$40.01M+$6.39M(+19.01%)
March 31, 2025

Summary

  • As of today (July 26, 2025), ABCL quarterly accounts receivable is $40.01 million, with the most recent change of +$6.39 million (+19.01%) on March 31, 2025.
  • Over the past year, ABCL quarterly accounts receivable has increased by +$5.59 million (+16.23%).
  • ABCL quarterly accounts receivable is now -88.04% below its all-time high of $334.40 million, reached on March 31, 2022.

Performance

ABCL Quarterly accounts receivable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherABCLbalance sheet metrics

Accounts receivable Formula

Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales

ABCL Accounts receivable Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+9.9%+16.2%
3 y3 years-79.1%-88.0%
5 y5 years+1482.7%-

ABCL Accounts receivable Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-79.1%+9.9%-62.3%+100.0%
5 y5-year-84.2%+1482.7%-88.0%+1329.3%
alltimeall time-84.2%+5544.1%-88.0%+1783.5%

ABCL Accounts receivable History

DateAnnualQuarterly
Mar 2025
-
$40.01M(+19.0%)
Dec 2024
$33.62M(+9.9%)
$33.62M(+7.1%)
Sep 2024
-
$31.37M(-13.2%)
Jun 2024
-
$36.14M(+5.0%)
Mar 2024
-
$34.42M(+12.5%)
Dec 2023
$30.59M(-20.7%)
$30.59M(-18.3%)
Sep 2023
-
$37.45M(-18.0%)
Jun 2023
-
$45.68M(+128.4%)
Mar 2023
-
$20.00M(-48.2%)
Dec 2022
$38.59M
$38.59M(-63.6%)
DateAnnualQuarterly
Sep 2022
-
$105.96M(+100.7%)
Jun 2022
-
$52.80M(-84.2%)
Mar 2022
-
$334.40M(+108.3%)
Dec 2021
$160.58M(-24.7%)
$160.58M(+268.0%)
Sep 2021
-
$43.63M(+1458.9%)
Jun 2021
-
$2.80M(-88.0%)
Mar 2021
-
$23.37M(-89.0%)
Dec 2020
$213.24M(>+9900.0%)
$213.24M(+3755.2%)
Sep 2020
-
$5.53M(+160.4%)
Dec 2019
$2.12M(+256.6%)
$2.12M
Dec 2018
$595.60K
-

FAQ

  • What is AbCellera Biologics Inc. annual accounts receivable?
  • What is the all time high annual accounts receivable for AbCellera Biologics Inc.?
  • What is AbCellera Biologics Inc. annual accounts receivable year-on-year change?
  • What is AbCellera Biologics Inc. quarterly accounts receivable?
  • What is the all time high quarterly accounts receivable for AbCellera Biologics Inc.?
  • What is AbCellera Biologics Inc. quarterly accounts receivable year-on-year change?

What is AbCellera Biologics Inc. annual accounts receivable?

The current annual accounts receivable of ABCL is $33.62M

What is the all time high annual accounts receivable for AbCellera Biologics Inc.?

AbCellera Biologics Inc. all-time high annual accounts receivable is $213.24M

What is AbCellera Biologics Inc. annual accounts receivable year-on-year change?

Over the past year, ABCL annual accounts receivable has changed by +$3.03M (+9.89%)

What is AbCellera Biologics Inc. quarterly accounts receivable?

The current quarterly accounts receivable of ABCL is $40.01M

What is the all time high quarterly accounts receivable for AbCellera Biologics Inc.?

AbCellera Biologics Inc. all-time high quarterly accounts receivable is $334.40M

What is AbCellera Biologics Inc. quarterly accounts receivable year-on-year change?

Over the past year, ABCL quarterly accounts receivable has changed by +$5.59M (+16.23%)
On this page